Back

Ablate and pace: the preferred therapy now?

5 April 2022 (09:06 - 09:18)
Organised by:
Congress Presentation Part of: Is there still room for drugs to control atrioventricular nodal conduction in atrial fibrillation (AF)? Atrial Fibrillation (AF) EHRA Premium Access EHRA 2022

About the speaker

Photo
Professor Panagiotis Vardas

University Hospital of Heraklion, Heraklion (Greece)

4 More presentations in this session

Presentation thumbnail
AV nodal blocking therapy in AF: when, how and for whom?
Professor S. Boveda (Toulouse, FR)
Slides Video
Presentation thumbnail
The role of digoxin in atrial fibrillation.
Professor P. Kirchhof (Hamburg, DE)
Slides Video
Presentation thumbnail
The role of a calcium channel blocker in atrial fibrillation.
Doctor R. Tieleman (Groningen, NL)
Slides Video
Presentation thumbnail
Is there still room for drugs to control AV nodal conduction in AF? - discussion.
Video

Access the full session

Session thumbnail
Is there still room for drugs to control atrioventricular nodal conduction in atrial fibrillation (AF)?
Video

The Event

Event poster

EHRA 2022

5 April 2022 09:06 CET
You may be interested in
thumbnail
Congress Presentation
Atrioventricular node ablation: when it is appropriate
thumbnail
Congress Presentation
AV nodal ablation and conduction system pacing
thumbnail
Congress Presentation
Pace and ablate: regularisation is everything

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources